|
![]() |
|||
|
||||
OverviewCyclosporin has had a remarkable effect on clinical organ transplantation. Prior to its introduction, considerable advances had been made in the grafting of vital organs, particularly the kidney, heart and liver. In many developed countries, however, transplantation was not considered wo-rthwhile in terms of gain for the investment of resources. The improved results of kidney grafts following the use of cyclosporin has changed this attitude. For all types of organ transplantation, cyclosporin has resulted in an improvement of functional graft survival and has allowed a reduction in steroid dose and, in some cases, no steroids at all. It has permitted the first successful experimental transplantation of the heart and lungs in primate species by Reitz and colleagues and their results were applied directly to the clinic. It was largely due to the introduction of cyclosporin that the Washington Consensus Meeting on Liver Transplantation came to a favourable recommendation and the result has been the proliferation of units performing liver transplantation, approximately fifty in North America and another fifty in Europe, where previously there had been a handful. Having been involved in cyclosporin for organ grafting from the beginning, I have been able to witness these developments which have far exceeded my expectations once the nephrotoxicity of cyclosporin was demonstrated in man. It is fitting that Dr. Full Product DetailsAuthor: A.W. ThomsonPublisher: Springer Imprint: Springer Edition: Softcover reprint of the original 1st ed. 1989 Dimensions: Width: 15.50cm , Height: 2.00cm , Length: 23.50cm Weight: 0.593kg ISBN: 9789401068741ISBN 10: 9401068747 Pages: 384 Publication Date: 26 September 2011 Audience: Professional and scholarly , Professional & Vocational Format: Paperback Publisher's Status: Active Availability: Manufactured on demand ![]() We will order this item for you from a manufactured on demand supplier. Table of Contents1 Inhibitory effects of cyclosporin A on lymphocyte activation.- 2 Effect of cyclosporin A on the immune response: pivotal role of the interleukin-2/interleukin-2 receptor autocrine pathway.- 3 Influence of cyclosporin A on humoral immunity and on B lymphocyte activation.- 4 The influence of cyclosporin A on T cell activation, cytokine gene expression and cell-mediated immunity.- 5 Cyclosporin A and tolerance induction in experimental animals.- 6 Prevention of graft rejection by cyclosporin A in man.- 7 Cyclosporin A and bone marrow transplantation.- 8 Cyclosporin A and intraocular inflammatory disease.- 9 Cyclosporin A in insulin-dependent diabetes.- 10 Cyclosporin A and skin disease.- 11 Cyclosporin A (Sandimmun®) in autoimmune disorders.- 12 Pharmacokinetics of cyclosporin A.- 13 Cyclosporin A metabolism and drug interactions.- 14 Pathological effects of cyclosporin A in experimental models.- 15 Pathological effects of cyclosporin A in clinical practice.ReviewsAuthor InformationTab Content 6Author Website:Countries AvailableAll regions |